Hardware Podcasts

How Proper Design Controls & a Quality System Could Save You $20M With Ronny Bracken

Global Medical Device Podcast · 7 Nov 2019 · 22m · Episode 6

What this episode covers

Ronny Bracken, Principal at Paladin Biomedical Consultants and COO for Nano Fiber Solutions and Innate Medical, explains how medical device startups often suffer a $20 million valuation haircut during mergers and acquisitions because their design controls and quality systems are inadequate. He argues that startups must embrace risk management as a tool for product improvement rather than a regulatory checkbox, and that large acquirers like Bard or Johnson & Johnson will significantly reduce offers if they have to rebuild Design History Files to mitigate compliance risks. Bracken emphasizes that startups need to generate revenue and clinical data, not just technology, to be attractive acquisition targets, and advises founders to 'lose early' if customer feedback indicates a lack of product-market fit.

Most relevant to

early-stage companies and large enterprises

Topics

Mentioned

Companies
Greenlight Guru, Paladin Biomedical Consultants, Nano Fiber Solutions, Innate Medical, Bard, Johnson & Johnson
Also
Ronny Bracken, FDA, ISO, 510 K, IDE, EU Mark

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

    Crowdfunding & preordersValidation & product-market fit
    8 chapters

  • Let's Combinate · 59m

    071 - Steel Industry to MedTech & Important Quality Systems with Etienne Nichols

    Etienne Nichols, host of the Global Medical Device Podcast and Medical Device Guru at Green Light Guru, discusses his transition from the steel industry to MedTech and his work on combination products. He emphasizes that document control (21 CFR 820.40) is critical for preventing costly errors, illustrating this with an anecdote about saving a $100,000 steel coupling from being scrapped due to a decimal error. Nichols argues that management responsibility is the most important quality system element, as it sets the cultural tone for prioritizing quality over speed, and highlights the importance of strong purchasing controls to ensure quality flows to contract manufacturers.

    Quality & yieldManufacturing partners & offshoring
    8 chapters

  • Let's Combinate · 17m

    217 - 5 Fixable Problems Holding Back Drug–Device Programs

    Subhi Saadeh, founder of Let’s Combinate BioWorks, outlines five critical quality issues in drug-device combination products, drawing on his experience at Pfizer, Gilead, and Baxter. He addresses documentation misalignment in design transfer, late manufacturing input, arbitrary sampling plans, unclear method transfer ownership, and supplier qualification gaps. Saadeh proposes solutions such as integrating pharma change controls with device design plans, embedding DFM/DFA reviews, and adopting PPAP frameworks for component qualification. The episode emphasizes harmonizing drug and device development processes to ensure scalable, compliant, and patient-ready solutions.

    Quality & yieldDesign for manufacturing & NPI
    1 chapters

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

    Validation & product-market fitManufacturing partners & offshoring
    8 chapters

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

    Quality & yieldStarting a product company
    8 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.